|
|
||||||||||
|
J Am Coll Cardiol, 2002; 39:1701 © 2002 by the American College of Cardiology Foundation |
a Dipartimento di Medicina Clinica e Scienze, Cardiovascolari ed Immunologiche, Cattedra di Geriatria, Università degli Studi di Napoli "Federico II", Via S. Pansini, 5, 80131 Napoli, Italy
p.abete{at}unina.it
2 years) and old (
4 years) rabbits (1). Reduction of infarct size on "in vivo" rabbits may be considered an appropriate experimental model to study ischemic PC in animals. However, when considered in cardiac aging, serious concerns arise about the experimental model involved in their study. Indeed, animal models are used in aging research to overcome the limitation of studying aging in humans (e.g., the relatively long life span of humans). Because most aspects of aging in rodents are similar to human aging despite their short life span, rats and mice have been used extensively to study the pathophysiology of aging (2).
In contrast, data on the senescent rabbit are not available because of its relative long life span. In fact, the maximum life span potential (MLSP) for rabbits is 13 years (3,4); thus, if we optimistically consider MLSP for humans as 100 years, a 4-year-old rabbit cannot be considered a good model of the aging heart. A 4-year-old rabbit could be compared to a
30-year-old human and obviously a 6-month-old rabbit to
4-year-old human. Accordingly, morphologic markers of cardiovascular aging are qualitatively but not quantitatively similar to that observed in well-studied models of aging. Przyklenk et al. (1) showed that mean myocyte cross-sectional area increased from 397 ± 7 µm2 in adult to 445 ± 11 µm2 in middle aged (+12%) and to 506 ± 10 µm2 in old (+27%) rabbits. In addition, the investigators also claimed that myocardial collagen content increased from 6.2 ± 0.3% in adult versus 10.8 ± 0.5% in old rabbit heart. In both cases, these age-related modifications are significantly smaller than that found by Anversa et al. (5), who demonstrated that myocyte cell volume increases up to
60% from adult to senescent rat hearts while collagen content increases from 7% in adult to 22% in senescent rat hearts. The modifications showed by Przyklenk et al. (1) are approximately half of those expected from a validated model of the aging heart.
Conversely, reduction of ischemic PC mechanism has been well established in a 24-month-old rat model (69) that proportionally represents a human being of age 60 (rat MLSP = 3.5 years) (2). Moreover, Przyklenk et al. (1) also showed a slight reduction of ischemic PC efficacy in two-year and three- to five-year versus four- to six-month-old rabbit (
15%). This is in agreement with the concept that pathophysiologic modifications that occur during aging are not "onoff" and that ischemic PC might have a progressive decline with aging. Infarct size progressively increases in the preconditioned rat heart (9) from
15% in adult animals (3 months), to
25% in middle-aged (12 months) and to
40% in old animals (20 months). Accordingly, as most of the age-related pathophysiologic modifications were observed in the senescent rat and human heart, ischemic PC was restored or preserved by antiaging interventions such as exercise training (10,11). On the basis of this evidence, ischemic PC efficacy should be significantly reduced also in 7- to 8-year-old rabbits that probably represent the 24-month-rat and 60-year-old human homologues of cardiac senescence.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Juhaszova, C. Rabuel, D. B. Zorov, E. G. Lakatta, and S. J. Sollott Protection in the aged heart: preventing the heart-break of old age? Cardiovasc Res, May 1, 2005; 66(2): 233 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Memtsoudis, A. H. S. The, and P. M. Heerdt Autonomic Mechanisms in the Age-Related Hypotensive Effect of Propofol Anesth. Analg., January 1, 2005; 100(1): 111 - 115. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |